- Home
- KPRX vs IHT Comparison
KPRX vs IHT Comparison
Compare KPRX & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPRX | IHT |
|---|---|---|
| Founded | 1998 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 12.6M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KPRX | IHT |
|---|---|---|
| Price | $2.47 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.4K | ★ 44.1K |
| Earning Date | 11-06-2026 | 09-16-2026 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.33 |
| 52 Week Low | $1.76 | $0.95 |
| 52 Week High | $2.91 | $1.90 |
Technical Indicators
Market Signals| Indicator | KPRX | IHT |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 31.65 |
| Support Level | $2.45 | $1.01 |
| Resistance Level | $2.61 | $1.27 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 4.55 | 25.90 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.